(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IMMUNIZEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IMMUNIZEN

ST13

US500000078038986

Class

5

Filing

78038986

Registration

2716548

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

12/23/2022

Trademark type

Word

Nice classes

5

Filing date

12/12/2000

Registration date

05/13/2003

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/23/2022

Last transaction

12/23/2022

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/31/2001

First use in commerce

01/31/2001

Drawing code

1

Owner type

03

Owner location

Orem, UT, US

Examiner

MAYS, PAULA

Law office

L20

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

UNICITY PROPERTIES, INC.
Enrich Corporation, The

Representatives

Preston C. Regehr TechLaw Ventures, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Nutritional and Dietary Supplements

Publications

History of USPTO decisions and trademark events.

37 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

12/23/2022

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

12/23/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/23/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/23/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

06/09/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/13/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/10/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/10/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/10/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/10/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/10/2020

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/03/2013

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

05/03/2013

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/03/2013

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

04/30/2013

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

04/30/2013

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

04/12/2013

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/10/2013

XXXX

POST REGISTRATION ACTION CORRECTION

04/10/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/09/2013

E89R

TEAS SECTION 8 & 9 RECEIVED

03/25/2013

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/17/2008

PLGL

ASSIGNED TO PARALEGAL

12/10/2008

E815

TEAS SECTION 8 & 15 RECEIVED

12/05/2008

CFIT

CASE FILE IN TICRS

03/26/2008

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/23/2007

R.PR

REGISTERED-PRINCIPAL REGISTER

05/13/2003

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/26/2003

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/25/2003

IUAF

USE AMENDMENT FILED

01/22/2003

EISU

TEAS STATEMENT OF USE RECEIVED

01/22/2003

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

12/03/2002

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

10/03/2001

PUBO

PUBLISHED FOR OPPOSITION

08/21/2001

NPUB

NOTICE OF PUBLICATION

08/01/2001

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/05/2001

DOCK

ASSIGNED TO EXAMINER

05/03/2001

Continuous trademark protection

Get notified about every new filing that threatens IMMUNIZEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.